ProTom International, Inc.
1100 Parker Square, Suite 230
Flower Mound, TX 75028
PROTON THERAPY RADIANCE 330® ABOUT NEWS CAREERS EVENTS CONTACT
 
IN THE
NEWS...
 


ProTom International Announces Purchase Agreement

ProTom International, Inc. ("ProTom") is pleased to announce the execution of a purchase agreement with Massachusetts General Hospital ("MGH") for the acquisition of a Radiance 330® Proton Therapy System ("Radiance 330") to be housed in the MGH Department of Radiation Oncology.

Read More >>


ProTom International, Inc. receives FDA 510(k) Clearance for its Radiance 330® Proton Therapy System

ProTom International, Inc., the developer and manufacturer of a technologically advanced proton beam radiation therapy system, announced today it has received 510(k) clearance for its Radiance 330 Proton Therapy System...

Read More >>


ProTom International Inc.'s Proton Cancer Therapy Technology A Texas Biotech Success Story

Flower Mound, Texas-based BioTech startup ProTom International, Inc. has received FDA 510(k) Clearance for its Radiance 330 Proton Therapy System. This clearance, officially making Radiance 330 commercially available, was instrumental in ProTom being awarded two new system orders — one at Massachusetts General Hospital (MGH), Boston and another at Atlantic Health System, New Jersey.

Read More >>


Acceptance Test Results of Proton Therapy Technology Exceeds Expectations

Initial acceptance test results of ProTom International, Inc.'s (“ProTom”) Radiance 330® Proton Therapy System (“Radiance 330”) are exceeding the expectations of medical physicists charged with clinical commissioning at the McLaren Proton Therapy Center (MPTC) in Flint, Michigan...

Read More >>


Proton Industry Leaders Join ProTom International

Susan Michaud, RT(T) has been named Vice President of Clinical Integration. Her proton therapy experience began with pioneers at Massachusetts General Hospital (MGH) treating patients at the Harvard Cyclotron Laboratory. Fuhua Wang has assumed the position of Accelerator Physicist. As Principal Research Scientist in the MIT Laboratory for Nuclear Science, Fuhua made extensive contributions during the testing and calibration of the Radiance 330 compact synchrotron, resulting in technology enhancements and several upgrades to the system...

Read More >>


Compact Proton Therapy Technology Achieves Scheduled December 2012 Milestone of Beam at Gantry Room Isocenter

Flower Mound, Texas/Flint, Michigan, USA — Testing of a compact cancer-treatment technology from ProTom International, Inc. (“ProTom”) demonstrated last week that the system achieves its design specification: delivering high-energy protons to isocenter at a beam intensity sufficient for standard clinical practice. The ProTom technical team measured stable and reproducible performance on the Radiance 330® Proton Therapy System at the McLaren Proton Therapy Center (“MPTC”) in Flint, Michigan.

Read More >>


ProTom International and Atlantic Health System
Partner in Fight against Cancer

Flower Mound, Texas/Morristown, New Jersey—ProTom International is proud to announce they have entered into an exclusive arrangement with New Jersey-based Atlantic Health System to provide the proton therapy system for the facility that will be built in its North Jersey marketplace. This facility will give Atlantic Health’s physicians and patients access to the most advanced form of treatment for many types of cancer.

Read More >>